Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET
Company Participants
Melanie Solomon - Investor Relations
Ming Hsieh - Chairman, Chief Executive Officer
Brandon Perthuis - Chief Commercial Officer
Paul Kim - Chief Financial Officer
Conference Call Participants
Li Lu - UBS
David Westenberg - Piper Sandler
Andrew Cooper - Raymond James
Operator
Greetings and welcome to the Fulgent Genetics Q3 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It’s now my pleasure to turn the call over to your host, Melanie Solomon, Investor Relations. Please go ahead.
Melanie Solomon
Good morning and welcome to the Fulgent third quarter 2024 financial results conference call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; and Brandon Perthuis, Chief Commercial Officer.
The company’s press release discussing the financial results is available on the Investor Relations section of the company’s website, fulgentgenetics.com. A replay of this call will be available shortly after the call concludes on the Investor Relations section of the company’s website.
Management’s prepared remarks and answers to your questions on today’s call will contain forward-looking statements. These forward-looking statements represent management’s estimates based on current views, expectations and assumptions, which may prove to be incorrect. As a result, matters discussed in any forward-looking statements are subject to risks, uncertainties and changes in circumstances that may cause actual results to differ from those described in the forward-looking statements.
The company assumes no obligation to update any of the forward-looking statements it may make today to reflect actual results or changes in expectations. Listeners should not rely on any forward-looking statements as predictions of future events and should listen to management’s remarks today with the understanding that actual events, including the company’s actual future results, may be materially different than what is prescribed in or implied by these forward-looking statements.
Please review the more detailed discussions related to these forward-looking statements, including the discussions of some of the risk factors that may cause results to differ from those described in the forward-looking statements contained in the company’s filings with the Securities and Exchange Commission, including the previously filed 10-K for the year-ended December 31, 2023 and subsequently filed reports, which are available on the company’s Investor Relations website.